GeoVax Labs, Inc. Strategy Supported by Encouraging Results of European Therapeutic HIV/AIDS Vaccine Trial - Drugs.com MedNews
Links shared publicly online about this topic.
- 692total visits
GeoVax Labs, Inc. Strategy Supported by Encouraging Results of European Therapeutic HIV/AIDS Vaccine Trial - Drugs.com MedNews
Success In Viral Load Reduction Control of Virus, By Vaccine Recipient s Immune System Who Have Been Weaned from ART Therapy Encouraging News for HIV AIDS Vacci
View full resource at drugs.com
Tags: Immune, Vaccination, HIV, AIDS, STD, Drug, Vaccine
Most Recently Shared on November 29, 2010 at 3:16 pm By:
GeoVax Labs, Inc. Strategy Supported by Encouraging Results of European Therapeutic HIV/AIDS Vaccine Trial... http://bit.ly/ehHsRn #drug
GeoVax Labs, Inc. Strategy Supported By Encouraging Results Of European Therapeutic HIV/AIDS Vaccine Trial
medicalnewstoday.com — “GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the Company), an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), announced it” View full resource at medicalnewstoday.com
Most Recently Shared on November 30, 2010 at 3:05 pm By:
GeoVax Labs, Inc. Strategy Supported By Encouraging Results Of European Therapeutic HIV/AIDS Vaccine Trial http://mnt.to/3Nhk #hivaids
Advertisement
